These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 206704)
1. Leukocyte migration inhibition and lymphocyte blastogenesis responses in breast carcinoma patients to mouse mammary tumor virus and to virion gp52 antigen and Rauscher murine leukemia virus-Kirsten sarcoma virus gp69/71 antigen. McCoy JL; Dean JH; Cannon GB; Jerome LJ; Alford TC; Parks WP; Gilden RV; Oroszlan ST; Herberman RB J Natl Cancer Inst; 1978 Jun; 60(6):1259-67. PubMed ID: 206704 [No Abstract] [Full Text] [Related]
2. Cellular hypersensitivity of gp55 of RIII-murine mammary tumor virus and gp55-like protein of human breast cancers. Black MM; Zachrau RE; Dion AS; Shore B; Fine DL; Leis HP; Williams CJ Cancer Res; 1976 Nov; 36(11 Pt 1):4137-42. PubMed ID: 184925 [TBL] [Abstract][Full Text] [Related]
3. Human lymphocyte blastogenesis responses to mouse mammary tumor virus. Wiseman CL; Bowen JM; Davis JW; Hersh EM; Brown BW; Blumenschein GR J Natl Cancer Inst; 1980 Mar; 64(3):425-30. PubMed ID: 6243719 [No Abstract] [Full Text] [Related]
4. Specificity of the simultaneous cell-mediated immune reactivity to RIII murine mammary tumor virus glycoprotein 55 and human breast cancer tissues. Zachrau RE; Black MM; Dion AS; Shore B; Williams CJ; Leis HP Cancer Res; 1978 Oct; 38(10):3414-20. PubMed ID: 80264 [No Abstract] [Full Text] [Related]
5. Leukocyte migration inhibition among breast cancer patients in response to various oncogenic viruses. Fukuda M; Wanebo HJ; Tsuei L; Ashikari R; Sarkar NH J Natl Cancer Inst; 1980 Mar; 64(3):431-7. PubMed ID: 6243720 [TBL] [Abstract][Full Text] [Related]
6. Murine sarcoma virus pseudotypes used as immunogens against viral and chemical oncogenesis. BasombrÃo MA; Mayer AM; Pasqualini CD Cancer Res; 1977 Jun; 37(6):1768-76. PubMed ID: 192461 [TBL] [Abstract][Full Text] [Related]
7. Detection in human breast carcinomas of an antigen immunologically related to a group-specific antigen of mouse mammary tumor virus. Mesa-Tejada R; Keydar I; Ramanarayanan M; Ohno T; Fenoglio C; Spiegelman S Proc Natl Acad Sci U S A; 1978 Mar; 75(3):1529-33. PubMed ID: 206905 [TBL] [Abstract][Full Text] [Related]
8. Assessment of cellular immune response to cancer of the breast. Herberman RB Ann Clin Lab Sci; 1979; 9(6):467-73. PubMed ID: 229763 [TBL] [Abstract][Full Text] [Related]
9. Detection of cell-mediated immune reactivity of breast cancer patients by the leukocyte adherence inhibition response to MCF-7 extracts. Rudczynski AB; Dyer CA; Mortensen RF Cancer Res; 1978 Nov; 38(11 Pt 1):3590-4. PubMed ID: 81103 [No Abstract] [Full Text] [Related]
10. Cell-mediated immunity to mouse mammary tumor virus antigens by patients with hyperplastic benign breast disease. Cannon GB; Barsky SH; Alford TC; Jerome LF; Tinley V; McCoy JL; Dean JH J Natl Cancer Inst; 1982 Jun; 68(6):935-43. PubMed ID: 6283226 [TBL] [Abstract][Full Text] [Related]
11. Cellular immunity to autologous breast cancer and RIII-murine mammary tumor virus preparations. Black MM; Zachrau RE; Shore B; Dion AS; Leis HP Cancer Res; 1978 Jul; 38(7):2068-76. PubMed ID: 207421 [No Abstract] [Full Text] [Related]
12. Indirect leukocyte migration inhibition in breast cancer and benign breast disease patients by mouse mammary tumor virus grown in feline kidney cells. McCoy JL; Tagliabue A; Ames RE; Teramoto YA; Cannon GB; Alford C; Herberman RB; Schlom J J Natl Cancer Inst; 1984 Mar; 72(3):569-76. PubMed ID: 6321840 [TBL] [Abstract][Full Text] [Related]
13. Presence of a mouse mammary tumor virus-related antigen in human breast carcinoma cells and its absence from normal mammary epithelial cells. Yang NS; McGrath CM; Furmanski P J Natl Cancer Inst; 1978 Nov; 61(5):1205-8. PubMed ID: 81881 [TBL] [Abstract][Full Text] [Related]
14. Leukocyte migration inhibition responses to MCF-7, murine mammary tumor virus, and Thomsen-Friedenreich antigen in a series of cancer patients. Bernhard MI; Wanebo HJ; Helm J; Pace RC; Kaiser DL Cancer Res; 1983 Apr; 43(4):1932-7. PubMed ID: 6299532 [No Abstract] [Full Text] [Related]
15. Effect of murine milk samples and human breast tissues on human leukocyte migration indices. Black MM; Moore DH; Shore B; Zachrau RE; Leis H Cancer Res; 1974 May; 34(5):1054-60. PubMed ID: 4363063 [No Abstract] [Full Text] [Related]
16. Lymphocyte inhibition by mammary tumor virus in patients with breast cancer. Moulton A; Gerfo PL; Suciu-Foca N; Silverstein G J Surg Res; 1974 Jun; 16(6):592-8. PubMed ID: 4366357 [No Abstract] [Full Text] [Related]
17. Immunogenicity and MuMTV-like antigenicity of human breast cancer tissues. Black MM Contemp Top Immunobiol; 1977; 6():239-62. PubMed ID: 194749 [No Abstract] [Full Text] [Related]
19. Lymphoproliferative responses to mouse mammary tumor virus in lymphocyte subsets of breast cancer patients. Lopez DM; Parks WP; Silverman MA; Distasio JA J Natl Cancer Inst; 1981 Aug; 67(2):353-8. PubMed ID: 6267344 [TBL] [Abstract][Full Text] [Related]
20. Human breast carcinoma antigen is immunologically related to the polypeptide of the group-specific glycoprotein of mouse mammary tumor virus. Ohno T; Mesa-Tejada R; Keydar I; Ramanarayanan M; Bausch J; Spiegelman S Proc Natl Acad Sci U S A; 1979 May; 76(5):2460-4. PubMed ID: 88056 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]